Trials / Unknown
UnknownNCT05090514
Ready to Read: Ready to Read: A School-Based Intervention to Promote Growth Mindset and Reading
Ready to Read: A School-Based Intervention to Promote Growth Mindset and Reading
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 5 Years – 9 Years
- Healthy volunteers
- Accepted
Summary
Primary Aim/Objective: To determine if a school-based intervention promoting reading with a growth mindset framework improves student reading achievement in the intervention group compared to a wait-list comparison group of children in kindergarten through 2nd grade. Secondary Aim/Objective: To determine if students whose parents endorse a fixed mindset with regard to student reading abilities show more improvement post-intervention than parents that endorse growth mindset. Secondary Aim/Objective: To determine if more parents endorse growth than fixed mindset post-intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Reading and Growth Mindset | Parents and students receive a packet of age-appropriate books and educational materials (flyer/handouts, link to educational video) on how to read together/promote reading with their child using growth mindset strategies and where to find other reading materials. Parents also receive 2 weekly text messages with tips and reminders to read with their child daily for 20 minutes over the course of 8 weeks. The messages contain a link to a secure Redcap survey to log days and time spent reading the prior week. |
| BEHAVIORAL | Wait-list Control | Parents and students receive a packet of age-appropriate books at the same time as the intervention group, but do not receive specialized instruction or reminders to read or any information on growth mindset and reading. |
Timeline
- Start date
- 2021-11-02
- Primary completion
- 2022-06-01
- Completion
- 2022-12-01
- First posted
- 2021-10-22
- Last updated
- 2022-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05090514. Inclusion in this directory is not an endorsement.